Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,479
Award facts
- Contract value 100% obligated
- $38,478.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $38,478.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 10, 2025, represents one of multiple orders placed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The IDC, awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy. No set-aside designation was applied to this delivery order, demonstrating the company's competitive capability in unrestricted federal procurement.
Under this delivery order and the underlying IDC, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products to Department of Defense healthcare facilities worldwide, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables. The company's product portfolio encompasses specialized categories such as oncology treatments, immunosuppressants, emergency medications, surgical products, and contraceptive devices. The IDC structure enables the Defense Logistics Agency to issue firm fixed-price orders for recurring military medical supply needs, with DMS Pharmaceutical Group's demonstrated performance on numerous prior delivery orders establishing its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMPG?
SPE2DU26FEMPG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DU26FEMPG worth?
The government has obligated $38,479 on SPE2DU26FEMPG.
Is contract SPE2DU26FEMPG an order under another contract?
Yes. SPE2DU26FEMPG is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPG competed?
The extent of competition for SPE2DU26FEMPG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award